by Katrina Carr | Apr 23, 2020 | Diagnosis & Therapy
As experts revise the guideline on management of chronic inflammatory demyelinating polyneuropathy, some in the clinical neurology field are calling for a regrouping of CIDP under a more general, overarching term, “CIDP syndrome” (CIDPS). This would include four...
by Katrina Carr | Apr 7, 2020 | Diagnosis & Therapy
style="width: 100%; margin: auto; display: block;" class="vidyard-player-embed" src="https://play.vidyard.com/Z1RiqTHz7RGfP3P7Nfbb4U.jpg" data-uuid="Z1RiqTHz7RGfP3P7Nfbb4U" data-v="4" data-type="inline"/ Electrodiagnostic testing frequently provides important...
by Katrina Carr | Mar 13, 2020 | Treatment
After receiving intravenous immunoglobulin (IVIg) to treat chronic inflammatory demyelinating polyneuropathy (CIDP) for nearly 20 years, Christina Caron heard about a recent immunoglobulin shortage via social media. Then, an outpatient center could not guarantee that...
by Katrina Carr | Mar 5, 2020 | Diagnosis & Therapy
For years, academic neuromuscular neurologists have anecdotally observed the overdiagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) in referred patients – and in the past 5 years, experts have documented the phenomenon and attempted to pinpoint...
by Katrina Carr | Feb 21, 2020 | Treatment
Early intervention is the key to minimizing disability for patients with chronic inflammatory demyelinating polyneuropathy (CIDP), and data from several recent studies support the monoclonal anti-CD20 antibody rituximab as a possible treatment when first-line...
